Jiangxi Fushine Pharmaceut (300497.SZ) traded flat 0 % during a 24 hours period ending at 11:11 AM Central Europe on Tuesday 27th. One Jiangxi Fushine Pharmaceut stock can currently be bought for about CNY 13.26 on popular exchanges. Current supply of Jiangxi Fushine Pharmaceut stocks is 538.6 mn. Jiangxi Fushine Pharmaceut has a current market capitalization of CNY 7.5 bn and approximately CNY 346.5 mn worth of Jiangxi Fushine Pharmaceut was traded on exchanges in the last 24 hours. Since last month end, Jiangxi Fushine Pharmaceut has traded -20.18 % down. Simple moving average of last 200 days is at CNY 18.02. The highest price of past 52 weeks was recorded at CNY 24.18 on 07/02/2026. 52 weeks low was at CNY 9.92 on 10/30/2025.
Here is how related stocks have performed in the past 24 hours:
Shanghai Datun Energy (600508.SS) traded flat 0 % and now trades at CNY 8.73. Shanghai Datun Energy has a market capitalisation of CNY 9 bn. Shanghai Datun Energy has a current price to earnings ratio of 30.15.
Ascentage Pharma Gr (6855.HK) traded down -0.72 % and now trades at HKD 27.9. Current market capitalisation for Ascentage Pharma Gr is HKD 10.6 bn.
Suzhou Veichi Electric (688698.SS) traded flat 0 % and now trades at CNY 37.91. Suzhou Veichi Electric has a market capitalisation of CNY 9 bn. Suzhou Veichi Electric has a current price to earnings ratio of 38.66.
Three’s Future Technolo (605168.SS) traded flat 0 % and now trades at CNY 40.62. Three’s Future Technolo has a market capitalisation of CNY 9 bn. Three’s Future Technolo has a current price to earnings ratio of 95.4. On October 26, a broad range of shares in China’s A‑share market saw significant block trades, totaling roughly 5.57 billion yuan. The largest single transactions were executed for companies such as Xiechuang Data, Rongtai Co., and Sanrenhang, each moving several hundred million yuan. Of the 40 stocks traded, the majority settled at or near their prevailing market prices, with a small number priced at a premium or discount. Premium trades were modest, exemplified by a 3 percent premium for Keda Xunfei, whereas notable discounts appeared for companies like Rui Chen Environment and Hui Sheng Biology. Institutional buyers and sellers were heavily involved, with Xiechuang Data leading in both buying and selling volumes, reflecting active interest from professional investors across the market.
Omh Science (300486.SZ) traded flat 0 % and now trades at CNY 17.68. Omh Science has a market capitalisation of CNY 9 bn. Omh Science has a current price to earnings ratio of 216.99.
About Jiangxi Fushine Pharmaceut
Jiangxi Fushine Pharmaceutical Co., Ltd. is a health care company operating in the pharmaceutical industry. The company, previously known as Jingdezhen Fuxiang Pharmaceutical Co., Ltd, specializes in conducting research, development, manufacturing, and selling APIs and pharmaceutical intermediates both nationally and internationally. Their product range includes penicillin, carbapenem, and other drugs. Additionally, they provide contract research, development, and manufacturing services. The company was founded in 2002 and has its main operations in Jingdezhen, China. Their website is accessible under www.fushine.cn and they are listed on the Shenzhen Stock Exchange.